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Abstract
Peripheral neuroinflammation is characterized by hematogenous mononuclear leukocyte infiltration into peripheral
nerves. Despite significant clinical knowledge, advancements in molecular biology and progress in developing
specific drugs for inflammatory disorders such as rheumatoid arthritis, inflammatory bowel disease, and multiple
sclerosis, there are currently no specific therapies that modulate pathogenic peripheral nerve inflammation.
Modeling leukocyte trafficking at the blood-nerve barrier using a reliable human in vitro model and potential
intravital microscopy techniques in representative animal models guided by human observational data should
facilitate the targeted modulation of the complex inflammatory cascade needed to develop safe and efficacious
therapeutics for immune-mediated neuropathies and chronic neuropathic pain.
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Background
Peripheral neuropathies are a very common group of
disorders that currently affect an estimated 20 million
people in the USA alone, and hundreds of millions of
patients worldwide. An estimated 20–30 % of cases are
cryptogenic or idiopathic, for which no known cause has
been determined despite extensive laboratory evaluation.
A major consequence of peripheral neuropathies is the
development of neuropathic pain, which affects over 1 %
of the US population [1, 2]. Treatments for neuropathic
pain are non-specific and provide moderate relief at best
[3]. Chronic pain syndromes associated with peripheral
neuropathies are often medically refractory, with treat-
ments costing the USA economy billions of dollars per
year in direct and indirect costs [4].
For acquired neuropathies where it is intuitively ex-
pected that pathologic interactions between the systemic
circulation and peripheral nerves play an important role
in disease initiation or progression or both, aberrant or
compromised function of the blood-nerve barrier (BNB)
could be key to fundamentally understanding how per-
ipheral neuropathies and neuropathic pain develop.
Relatively little is known with regards to the function,
significance, and mechanisms of pathogenic alterations
at the BNB. When functioning properly, the BNB regu-
lates the movement of solutes, macromolecules, and
leukocytes from the circulating blood to the innermost
aspects of peripheral nerves and nerve roots, known as the
endoneurium [5–7]. Structural alterations such as changes
in intercellular junctions associated with leukocyte traffick-
ing and basement membrane thickening/duplication at the
BNB have been implicated in the pathogenesis of inflam-
matory neuropathies and diabetes mellitus [8–12].
Immune-mediated peripheral neuropathies, such as
Guillain-Barré syndrome (GBS) and chronic inflamma-
tory demyelinating polyradiculoneuropathy (CIDP), have
* Correspondence: eeubogu@uabmc.edu
Department of Neurology, Neuromuscular Immunopathology Research
Laboratory, Division of Neuromuscular Disease, The University of Alabama at
Birmingham, 1825 University Boulevard, Room 1131, Birmingham, AL
35294-0017, USA
© 2016 Greathouse et al. Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to
the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
Greathouse et al. Journal of Neuroinflammation  (2016) 13:3 
DOI 10.1186/s12974-015-0469-3
unknown or incompletely understood triggers; however,
the presence of hematogenously derived monocytes/mac-
rophages and T-lymphocytes in affected patient nerve
biopsies implies a pathogenic role for leukocyte infiltration
across the BNB [9, 13–15]. Similarly, there is evidence sup-
porting mononuclear and polymorphonuclear leukocyte
infiltration from the blood circulation into peripheral
nerves in the development of chronic neuropathic pain
based on animal models [16–20], although direct evidence
from patients is lacking.
Neutrophil infiltration has been shown to correlate with
increased pain perception in a rat model of partial sciatic
nerve transection [20]. Chemokine receptor CCR2+
monocytes/macrophages have also been implicated in
chemical-induced inflammatory pain responses and nerve
ligation/chronic constriction-induced hypersensitivity to
mechanical pain (mechanical allodynia) in rats and mice
[21–23], with chemokine receptor CX3CR1+ monocytes
associated with chemotherapy (vincristine)-induced allo-
dynia in mice [16]. T-lymphocyte infiltration with subse-
quent secretion of proinflammatory cytokines such as
interleukin (IL)-17A, IL-23, and IL-15 has also been impli-
cated in the pathogenesis of neuropathic pain in the
chronic constriction injury model in mice [24, 25], while
CD4+ CD25+ Foxp3+ regulatory T-cells have been shown
to modulate mechanical allodynia following sciatic nerve
chronic constriction injury and experimental autoimmune
neuritis in rats [26].
Guided by these observations, we can infer that in-
hibition of leukocyte infiltration at onset or earlier
stages of disease progression could reduce the extent
of demyelination and axonal injury in immune-
mediated neuropathies and development of chronic
pain in inflammatory and traumatic neuropathies,
resulting in improved patient outcomes in these disor-
ders. This review article will explore recent advances of
in vitro leukocyte trafficking models at the BNB and
discuss the potential application of intravital micros-
copy for in vivo study in animal models. Emerging
knowledge from these models based on hypothesis-
driven experiments focused on the determinants and
signaling pathways for specific leukocyte subpopulation
chemoattraction, arrest, transmigration (paracellular or
transcellular), and local tissue migration could guide
targeted anti-inflammatory drug therapies directed at
pathogenic leukocyte trafficking in human peripheral
nerve disorders.
Peripheral nerve anatomy and the blood-nerve
barrier
In order to effectively develop targeted molecular ther-
apies for inflammatory neuropathies, one must first
have an understanding of peripheral nerve structure
and the BNB. Peripheral nerves consist of an external
epineurium, inner perineurium, and innermost endo-
neurium (Fig. 1). The endoneurium is of critical im-
portance as axons and their associated Schwann cells,
which either myelinate segments of single axons or
envelope clusters of small axons without myelination,
reside within it [7, 27–29]. These myelinated and un-
myelinated axons are responsible for signal transduc-
tion to and from peripheral nerves. The endoneurial
microenvironment is strictly regulated by endoneurial
microvascular endothelial cells that form the BNB, as
these cells are in direct contact with circulating
blood. Perineurial myofibroblasts that form a concen-
tric multilayered barrier around the endoneurium pre-
venting passive influx of epineurial interstitial fluid
into the endoneurium or efflux of endoneurial inter-
stitial fluid into the epineurium also play an import-
ant role in endoneurial homeostasis [27–31]. The
perineurium and the endoneurium it surrounds form
a fascicle or nerve bundle, aligned parallel to the lon-
gitudinal axis of the nerve. Human peripheral nerves
consist of multiple fascicles, with the sciatic nerve
(the largest nerve in the body) possessing 50–80 fas-
cicles [32]. This is in contrast to the mouse sciatic
nerve that may possess 1–4 fascicles enveloped within
a thin epineurial layer [33].
Endoneurial endothelial cells and the innermost
layer of perineurial myofibroblasts regulate solute and
macromolecular transport, as well as leukocyte entry
into the endoneurium due to their specialized inter-
cellular adherens and tight junctions and lack of
fenestrae [27, 30, 31, 34, 35]. In contrast, blood ves-
sels within the epineurium do not form a restrictive
barrier between the systemic circulation and the epi-
neurial interstitium, as they lack tight junctions and
possess fenestrae [28, 29]. Detailed description of the
molecular and biophysical properties of the human
BNB in vitro and similarities to and differences from
the human blood-brain barrier based on comparative
studies using immortalized cell lines have been recently
published [6, 32, 36]. Human endoneurial endothelial
cells that form the BNB are Ulex europaeus agglutinin-
and von Willebrand factor-positive, and endocytose
acetylated low-density lipoproteins (demonstrating ex-
pression of specific lipid scavenger receptors). These
cells form intercellular adherens junctions (vascular endo-
thelial cadherin-positive) and electron dense tight junc-
tions (occludin, claudin-5, zona occludens-1 and -2-
positive) in vitro and demonstrate high transendothelial
electrical resistance and low solute permeability to low
and high molecular weight molecules consistent with a re-
strictive microvascular barrier [6, 32, 37].
These specialized microvascular endothelial cells
also express selective mitogen receptors such as vas-
cular endothelium growth factor receptor-2 and glial
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cell line-derived neurotrophic factor family receptor
alpha-1 that drive proliferation, differentiation, re-
sponse to injury and restoration of barrier function
[37, 38]; specific enzymes such as alkaline phosphat-
ase and γ-glutamyl transpeptidase; nutrient trans-
porters such as glucose transporter-1 (GLUT-1), large
neutral amino acid transporter-1, and monocarboxylate
transporter-1 (MCT-1); and xenobiotic transporters such
as p-glycoprotein (also known as multidrug resistance-1a)
and organic anion transporter-3 [6, 32, 36]. The retention
of essential molecular and biophysical properties expected
for a tight junction forming restrictive microvascular bar-
rier in vitro by human endoneurial endothelial cells pro-
vides a tool to elucidate key determinants and signaling
mechanisms relevant for understanding systemic-neural
interactions in health and disease at the BNB.
Leukocyte trafficking at the blood-nerve barrier
The mechanisms of leukocyte infiltration across the
BNB are at the early stages of elucidation, guided by
observations in other microvascular barriers. Leukocyte
trafficking across the endothelium is a sequential, coor-
dinated process driven by interactions between selec-
tins (such as E- and P-selectin), chemokines, cell
adhesion molecules (such as intercellular adhesion
molecule-1 (ICAM-1) and vascular cell adhesion
molecule-1 [VCAM-1]) expressed on the endothelial
cell luminal membrane, and ligands (such as P-selectin
glycoprotein-1), chemokine receptors, and integrins
expressed by circulating leukocytes. This is referred to
as the multi-step paradigm for leukocyte trafficking.
Leukocyte rolling, adhesion, and transmigration have
been described by pathologists and vascular biologists
Fig. 1 Peripheral nerve structure and vascular supply. A digital photomicrograph of a FITC-conjugated Ulex europaeus agglutinin-1 (green) stained
frozen section of a human sciatic nerve counterstained with DAPI (blue) demonstrates the compartmentalized organization of peripheral nerves,
with an epineurial macrovessel depicted in (a) and an endoneurial microvessel that forms the blood-nerve barrier depicted in (b). Endoneurial
microvessels are capillary-like and are derived from epineurial macrovessels that penetrate the perineurium
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for many years. However, additional steps have been
identified that are crucial for leukocyte migration,
dependent on the specific microvascular bed: tethering,
slow rolling, adhesion strengthening and spreading,
intravascular crawling, and paracellular and transcellular
transmigration [39]. Due to the important pathogenic
role of hematogenous leukocyte infiltration across the
BNB in immune-mediated neuropathies and possibly
neuropathic pain as suggested by animal models, it is
crucial to have model systems that directly evaluate
leukocyte trafficking events at the BNB in real time. In
vivo animal and in vitro human models serve as
complimentary tools in the quest to elucidate the deter-
minants and signaling pathways of specific leukocyte
subpopulation trafficking in peripheral nerves required
develop targeted molecular therapies for pathogenic
immune-mediated inflammatory neuropathies and pos-
sibly neuropathic pain.
In vitro models of leukocyte trafficking at the
blood-nerve barrier
Mechanisms of leukocyte infiltration into the endoneur-
ium are pathologically relevant to immune-mediated neu-
ropathies, such as GBS and CIDP. There are currently no
models that allow direct evaluation of leukocyte traf-
ficking in peripheral nerves in vivo. Developing a near-
physiological human in vitro BNB has been essential to
understanding possible mechanisms of leukocyte-
endothelial interactions in vivo [40]. Static and flow-
dependent leukocyte trafficking models have provided
significant insight into the normal and pathologic me-
diators of leukocyte subpopulation entry to tissues in
different disease states [41, 42]. Direct comparison of
flow-dependent (in which endothelial cells are exposed
to shear stress) and static blood-brain barrier models
showed enhanced endothelial cell differentiation and
restrictive barrier characteristics that are further en-
hanced by culturing endothelial cells on modified
hollow chambers with microscopic pores that mimic
capillaries [43, 44]. Furthermore, recent studies have
demonstrated the importance of flow and shear forces
on leukocyte trafficking via induction of selectin-
dependent rolling (which is absent in static models),
chemokine-dependent integrin activation and arrest, as
well as generation of mechanical signals that directly
influence biochemical responses of endothelial cells to
facilitate leukocyte extravasation such as cytoskeletal
alterations during diapedesis [45]. In addition to the
importance of flow and shear forces to endothelial cell-
leukocyte interactions, there is phenotypic and functional
heterogeneity between endothelial cells from different
species and tissues, as well as between macrovascular and
microvascular endothelial cells from within the same
tissue [46–52].
Ultrastructural examination of epineurial macrovessels
in peripheral nerves demonstrates lack of electron dense
intercellular tight junctions that are present in endo-
neurial microvessels [28, 29]. Endoneurial microvessels
also specifically express alkaline phosphatase [47]. While
GLUT-1 and p-glycoprotein expressions are highly con-
served in several species (e.g., human, cow, guinea pig,
and rat), MCT-1 expression has been demonstrated by
human endoneurial endothelial cells (and possibly
rabbit), with absent expression in the mouse and rat
[32]. Leukocyte trafficking in peripheral nerves predom-
inantly occurs across endoneurial microvessels in
immune-mediated peripheral neuropathies such as GBS
and CIDP and their rodent animal models, as well as
animal models of neuropathic pain, rather than epineur-
ial macrovessels [23, 53]. The preferential trafficking of
activated leukocytes across microvascular endothelium
(capillaries and post-capillary venules) rather than
macrovascular endothelium (e.g., arterioles and venules)
during inflammation is evolutionally conserved down to
the hagfish dermis [50]. It is therefore paramount to
directly study homeostatic leukocyte-BNB endothelial
cell interactions relevant for peripheral nerve immune
surveillance, as well as pathologic leukocyte trafficking
relevant to human peripheral neuroinflammation in vitro
using a human BNB cell line incorporating near normal
physiological flow and shear forces, and not simply
extrapolate from other vascular barriers such as the
blood-brain barrier or use endothelial cells from different
species or tissues that may differentially express proin-
flammatory cytokines, chemokines, and cell adhesion
molecules.
Leukocyte trafficking across the BNB can be studied in
real time using a flow-dependent leukocyte trafficking
assay that entails a parallel plate flow chamber coupled
to time-lapse video microscopy [40, 54–58] (Fig. 2). Pri-
mary human endoneurial endothelial cells (pHEndECs)
that form the restrictive human BNB have been isolated
from the sciatic nerves of decedent patients for culture
and used in leukocyte trafficking assay experiments.
There is evidence that pHEndECs retain essential mo-
lecular and biophysical characteristics of a restrictive
microvascular barrier in vitro when cultured in special-
ized culture medium supplemented with growth factors
for up to eight passages [6, 32]. These cells can be
seeded on rat-tail collagen-coated CellBIND® petri dishes
that facilitate their attachment, proliferation, and contact
inhibition. Confluent endothelial cell layers are ready for
use in experiments after 5–7 days in culture, forming an
in vitro BNB barrier [40, 58].
The in vitro BNB may be treated with physiological
concentrations of proinflammatory cytokines (e.g., tissue
necrosis factor-α and interferon-γ) up to 48 h prior to
experiments to promote leukocyte trafficking without
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passively altering transendothelial resistance or inducing
endothelial cell death [40]. Studying basal leukocyte mi-
gration without exogenous cytokine treatment of the
BNB may provide insights relevant to the determinants
and signaling pathways relevant to peripheral nerve im-
mune surveillance in normal, healthy individuals. This
process may be compromised in patients with human
immunodeficiency virus infection with peripheral neu-
ropathies. Cytokine-mediated endoneurial endothelial
cell activation using concentrations of tissue necrosis
factor-α and interferon-γ within the range demonstrated
in patients’ sera was associated with de novo or increased
expression of chemokines such as CCL2, CXCL2-3,
CXCL8, CXCL9, CXCL10, and CXCL11, as well as
selectins and cell adhesion molecules such as E-selectin,
P-selectin, ICAM-1, VCAM-1, and the alternatively
spliced fibronectin variant, connecting segment-1 (a
counterligand for leukocyte α4 integrin) [40]. These
chemokines have been shown to mediate monocyte/
macrophage (CCL2), neutrophil (CXCL2-3, CXCL8),
and CD4+ T-helper 1 lymphocyte (CXCL9, CXCL10,
CXCL11) transmigration [59]. The repertoire of cell
adhesion molecules expressed supports leukocyte roll-
ing, adhesion and transmigration in vitro and in vivo
based on studies from human brain and non-neural
microvessels.
Peripheral blood mononuclear leukocytes (PBMLs)
from untreated patients with immune-mediated neurop-
athies such as GBS or CIDP, or patients with chronic
neuropathic pain can be infused across the BNB model
at predefined flow rates or shear forces that mimic esti-
mated capillary hemodynamics in peripheral nerves. In
this model system, firmly adherent PBMLs become
noticeable within seconds and start to form adherent
clusters with transmigration after about 5 min, with an
increase in the number of attached and transmigrated
PBMLs over time, reaching a peak between 20 and
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Fig. 2 Flow-dependent in vitro blood-nerve barrier model. This illustration depicts a set-up for the flow-dependent in vitro blood-nerve barrier
model system that allows direct visualization of human leukocyte trafficking at the BNB in real time using time-lapse video microscopy. Leukocytes
are infused at physiologically relevant flow rates and leukocyte-endothelial interactions captured by sequential digital photomicrographs that are
merged into videos and analyzed under different experimental conditions. Black arrows depict the direction of leukocyte flow
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determinants and role(s) of different signaling mecha-
nisms on leukocyte trafficking at the BNB at different
stages of the cascade, function neutralizing monoclonal
antibodies or small molecular antagonists can be added
to the leukocytes or applied to the BNB prior to per-
forming the assay. The effect of leukocyte activation and
different stages of a disease on leukocyte trafficking may
also be studied using leukocytes obtained from different
patients with the same inflammatory neuropathy charac-
terized for activation markers by flow cytometry and leu-
kocytes obtained from the same patient at disease onset,
peak severity, and during the recovery phases, respectively.
Based on our review of hundreds of videos generated in
the Neuromuscular Immunopathology Research Labora-
tory using PBMLs from healthy donors and untreated
patients with immune-mediated neuropathies, our initial
observations of leukocyte trafficking at the human BNB in
vitro are as follows: as hypothesized by the multi-step
paradigm of leukocyte extravasation at vascular beds,
leukocyte trafficking at the human BNB consists of rolling,
attachment with or without post-adhesion locomotion to
sites presumed to express high concentrations of chemo-
attractant molecules (haptotaxis), firm adhesion concen-
trated at intercellular membranes, and transmigration via
the paracellular route. Endothelial cell cytokine activation
is a stronger stimulus for leukocyte trafficking than
systemic leukocyte activation that occurs in GBS. GBS
patient-derived mononuclear leukocytes preferentially
adhere to the BNB in vitro (Additional file 1: Video 1),
dependent on αM integrin-ICAM-1 mediated signaling
(Additional file 1: Video 2), with CD14+ monocytes being
the most prevalent adherent leukocyte subpopulation [40].
Monocytes/macrophages are the most prevalent leukocyte
subpopulation observed within the endoneurium in
peripheral nerve biopsies of human GBS and its represen-
tative animal model, experimental autoimmune neuritis
(EAN) [60, 61], further validating the utility of the flow-
dependent in vitro BNB model to understand pathogenic
leukocyte trafficking in peripheral nerves in vivo.
By using pHEndECs as well as patient-derived PBMLs
with estimates of capillary flow rates and alterations in
the endoneurial microenvironment in vivo, this in vitro
human BNB model currently provides the most physio-
logic means to study human peripheral nerve inflamma-
tion pathogenesis as a tool to guide the discovery and
potential efficacy of specific molecular-based target
drugs to treat immune-mediated neuropathies such as
GBS and CIDP. Our previous work demonstrated the
differential expression αM integrin (CD11b) on GBS
patient leukocyte subpopulations and its critical role in
leukocyte transmigration via ICAM-1 at the BNB using
this model [40], suggesting potential efficacy in GBS that
is currently being tested in animal models. There are no
leukocyte trafficking assays published using other human
primary or immortalized endoneurial endothelial cells.-
Static leukocyte assays using CCR2-expressing human
acute monocytic leukemia cell line and primary or im-
mortalized rat endoneurial endothelial cells [62, 63] pro-
vide some insights relevant to understanding peripheral
neuroinflammation but neither utilize patient-derived leu-
kocytes nor a human BNB model, limiting translational
potential due to likely interspecies differences and the in-
adequacies of static transmigration assays.
Limitations of the described flow-dependent human in
vitro BNB model include the use of a parallel plate system
rather than a hollow, capillary-like, microtube chamber
that allows more accurate application of physiological
shear forces; the absence of an abluminal compartment to
apply chemoattractant molecules and collect transmi-
grated leukocytes for downstream analyses; suspension of
patient-derived leukocytes in medium with less viscosity
than circulating blood, potential alterations (e.g., downreg-
ulation in chemokine receptors) with cryopreserved
patient-derived leukocytes ex vivo, potential changes in
BNB endothelial biology with in vitro culture; and un-
known effects of endothelial cell culture without poten-
tially supportive Schwann cells and pericytes. Despite
these limitations, this model provides an avenue to deter-
mine whether endothelial cytokine activation or leukocyte
activation state influences leukocyte rolling velocities and
probability of firm leukocyte arrest, determine which che-
mokine ligand-receptor pairs are crucial for leukocyte
subpopulation arrest and integrin activation, as well as
subsequent transmigration at the BNB, determine the
differential roles of ICAM-1, VCAM-1, and fibronectin
connecting segment-1 in specific leukocyte subpopula-
tion adhesion as well as the signaling mechanisms
involved in leukocyte docking at intercellular junc-
tions and paracellular migration at the human BNB
relevant to normal immune surveillance and patho-
genic neuroinflammation.
In vivo models of leukocyte trafficking at the
blood-nerve barrier
There are currently no models that permit direct assess-
ment of leukocyte trafficking across the BNB in real time
in vivo. However, there are various microscopic techniques
that allow us to visualize leukocyte trafficking in vivo that
may advance our understanding of the multi-step para-
digm and provide technical considerations that could
guide peripheral nerve leukocyte trafficking studies in the
future. The structural organization of peripheral nerves
provides a challenge to directly viewing leukocyte traffick-
ing at the BNB in vivo as these low-density microvessels
are located within the innermost endoneurium surrounded
by axons and loose arrays of collagen fibers aligned in
parallel with these microvessels. Furthermore, the endo-
neurium is surrounded by the multilayered perineurium
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(forming a fascicle or nerve bundle), and these nerve bun-
dles are embedded within the epineurium consisting of
longitudinal arrays of collagen fibers. Superficial extrinsic
peripheral nerve blood vessels (i.e., the vasa nervorum)
and epineurial macrovessels are theoretically easier to
visualize; however, these vessels lack tight junctions and
possess fenestrations and as a consequence are not part of
the restrictive BNB (Fig. 3). Visualizing leukocyte traffick-
ing in small rodent peripheral nerves is conceptually more
likely than in higher mammals due to a thinner epineu-
rium and perineurium, as well as fewer fascicles in ana-
tomically similar nerves.
Intravital microscopy (IVM) techniques have been used
for decades with bright field transillumination to help sci-
entists understand the biophysical conditions under which
leukocytes are exposed to in microvessels [64–66]. Thus,
IVM provides a tool to acquire quantitative, qualitative,
and dynamic insights into cell biology and endothelial-
leukocyte interactions relevant to understanding the
pathophysiology of inflammation in different disease states
[67]. Over the last decade, technological advances have
been applied to IVM allowing dynamic visualization of
leukocyte trafficking within deep tissues. Such
advances include application of single, and subse-
quently multibeam two-photon microscopy, dual or
multicolor two-photon imaging, and epi-illuminescence
fluorescent microscopy facilitated by injecting specific
dyes into rodents intravenously or intraperitoneally. These
allow for the visualization and tracking of leukocytes in
the brain in vivo with improved temporal and spatial
resolution [68–72].
Brightfield IVM is a basic technique used to observe
leukocyte trafficking; however, ideal tissues must be
translucent and cannot contain any internal structures
that scatter or absorb light. This is not the case in per-
ipheral nerves with the multilayered organization that
consists of longitudinal arrays of collagen fibrils within
the epineurium and less compact arrays within the
endoneurium in which the microvessels reside with mye-
linated and unmyelinated axons. This along with the fact
that at physiological flow rates, leukocytes may be ob-
scured by rapidly moving red blood cells make this an
impractical model to observe leukocyte infiltration at the
BNB. Furthermore, only cells that are clearly rolling or
stationary can be detected by this technique [68]. More
















Fig. 3 Intravital microscopy of human peripheral nerve. The challenges of visualizing leukocyte trafficking in endoneurial microvessels that form the
blood-nerve barrier by intravital microscopy due to the multilayered organization of the human peripheral nerve are demonstrated in this illustration.
Barriers that impede clear detection of leukocytes within these microvessels include axons and surrounding connective tissue within the endoneurium,
the concentric and multilayered perineurium, and the longitudinally aligned collagen fibers and fat globules with the epineurium. The extrinsic vasa
nervorum and epineurial macrovessels should be avoided as these blood vessels lack tight junctions and possess fenestrations
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leukocyte trafficking observation including two-photon
microscopy which can be synchronized with second har-
monic generation signals derived from the extracellular
matrix [73–75]. The end result is the visualization of im-
mune cell migration and cell-cell communication in the
interstitium of solid organs and the brain via intracranial
windows [75–77].
A limitation of single beam two-photon IVM is the re-
quirement of higher laser power to enhance sensitivity
and detection speed which results in sample degradation.
Multibeam two-photon IVM using a multifocal scan head
that splits a laser beam into a line of 64 foci with charge-
coupled device field detector allows real-time sample illu-
mination at full power. This technique has been shown
visualize tissues down to penetration depths of 200 μm at
an image quality similar to surface detection after applying
depth-correction point of spread function [70]. However,
single two-photon IVM with laser detection using photo-
multipliers generated better images at depths >300 μm
due to superior signal-to-noise ratio.
Epi-luminescence fluorescent IVM can be applied to
track leukocyte trafficking in vivo by injecting specific
fluorophores or fluorescent dyes that facilitate the
detection of microvessels. Using Rhodamine 6G to
visualize real-time leukocyte-endothelial interactions in
the brain, intraperitoneal administration was demon-
strated to be as effective as the standard intravenous
injection route [72]. However, the intense excitation of
light that may be necessary for visualization can cause
phototoxic effects that may manifest as enhanced
leukocyte adhesion [68]. As opposed to injecting a dye
to illuminate microvessels, leukocyte populations can
be tagged in vitro before injection into an animal
model. Once injected into the recipient animal, the
cells are easily detectable because they are the only
fluorescent cells in circulation [78]. In addition to
studying inflammation, these techniques may be used
to study brain tumors in living animals (typically
employing two different fluorescent tags). Transgenic
mouse models with targeted cell populations labelled
with fluorescent proteins of different colors have been
used for six-color two-photon IVM of malignant brain
tumors generating 5D images in which individual cell
populations and components of the extracellular matrix
can be separated by spectral deconvolution [71].
IVM and two-photon microscopy have been employed
to visual leukocyte-endothelial interactions and elucidate
determinants of leukocyte trafficking in mouse models of
central nervous system inflammation such as experimen-
tal autoimmune encephalomyelitis (an animal model of
multiple sclerosis) [79–83], endotoxin-induced inflamma-
tion [67, 84–86], herpes simplex virus-1 encephalitis [87]
and cryptococcal meningoencephalitis [88]; controlled
cortical impact injury model of traumatic brain injury [89]
and in healthy living brain slices [75]. Epifluorescence
IVM is more suitable to investigate leukocyte-endothelial
interactions, particularly tethering and rolling, signal
transduction pathways controlling integrin activation, slow
rolling, arrest, and adhesion strengthening in the central
nervous system vessels, while multiphoton microscopy is
more suitable for the investigation of intraluminal crawl-
ing, transmigration, and motility inside the CNS paren-
chyma [90].
Although it has been debated whether IVM adequately
visualizes deeper-residing cerebral post-capillary venules
that form the blood-brain barrier in addition to superfi-
cial vessels that do not, these studies have been useful in
determining the role of proinflammatory signals: micro-
glial and endothelial activation, Toll-like receptors,
specific selectins and their counterligands, leukocyte
integrins and endothelial cell adhesion molecules, and
chemokines and chemokine receptors; as well as anti-
inflammatory signals such as cannabinoid receptor-2
and annexin A1 interacting with its receptor FRR2/ALX
in trafficking of total leukocyte or leukocyte subpopula-
tion such as T-cells (naïve and autoaggressive, antigen-
specific), neutrophils or dendritic cells in the central
nervous system inflammation [67, 75, 79–89].
Hopefully, the advances made in IVM and two-photon
microscopic techniques to visualize leukocyte trafficking
in the central nervous system will guide approaches
needed to study leukocyte trafficking across the BNB in
the near future. These approaches if applicable to the
mouse sciatic nerve may aid to elucidate the molecular
determinants and signaling mechanisms relevant to T-cell
immune surveillance in healthy nerves, monocyte, T-cell,
and neutrophil trafficking into the endoneurium at differ-
ent stages of acute and chronic immune-mediated demye-
linating neuritis or peripheral neuropathy following nerve
crush injury, as well as aid to determine the leukocyte
subpopulations and molecular signals essential for periph-
eral nerve recovery following inflammation and trauma.
These observations could translate to human peripheral
nerves due to similarities in neural-immune responses
between mice and humans.
Since IVM approaches have not been developed for per-
ipheral nerves, leukocyte trafficking at the BNB in vivo is
currently studied indirectly using animal models of per-
ipheral nerve inflammation. Animal models of acute and
chronic demyelinating neuritis such as EAN, chronic-
relapsing EAN, and spontaneous autoimmune peripheral
polyneuropathy (SAPP) have been used to aid decipher
relevant mediators and signaling mechanisms of patho-
genic leukocyte trafficking that should be preferably
guided by in situ observational data from peripheral
nerves obtained from affected patients [53]. Despite the
fact that these models recapitulate some essential fea-
tures of the human disorder they mimic, a major
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drawback is that these animal models do not allow real-
time assessment of leukocyte trafficking at the BNB
and may utilize signaling mechanisms irrelevant to
human GBS, CIDP, or chronic neuropathic pain. None-
theless, pharmacologic intervention studies in these
models using drugs efficacious at nanomolar or low mi-
cromolar concentration may provide in vivo proof of
principle necessary for early stage clinical trials. Drugs
should be administered after clearly discernable neuro-
muscular dysfunction at time periods reflective of
human disease presentation, thereby increasing transla-
tional relevance. It is hoped that insights obtained from
these animal models will not only further our under-
standing of leukocyte trafficking in peripheral nerves
but also provide specific molecular targets for treating
pathogenic leukocyte trafficking in immune-mediated
polyneuropathies and possibly chronic neuropathic
pain.
Conclusions
Currently available treatments for immune-mediated
neuropathies and chronic neuropathic pain are partly ef-
ficacious or focus on symptom control. Recent advances
in cell and molecular biology as well as medicinal chem-
istry and pharmacology should drive the development of
specific therapies for these disorders. Although other
pathologic aspects of peripheral nerve inflammation and
nerve recovery after injury are important considerations,
knowledge of aberrant leukocyte infiltration at the BNB
has potential to halt the deleterious effects of hemato-
genously derived leukocytes in these disorders. In a simi-
lar vein, care would be required not to impede the
trafficking of regulatory leukocyte subpopulations into
the peripheral nervous system and be aware of the po-
tential potent systemic immunosuppressive properties
specific anti-inflammatory drugs could possess. Using in
vitro and in vivo models designed to mimic essential as-
pects of human peripheral nerve inflammation guided
by observational human peripheral nerve data, know-
ledge obtained will help further elucidate important sig-
naling pathways and hopefully guide the development of
more specific and efficacious treatments for pathologic
peripheral nerve inflammation.
Additional file
Additional file 1: GBS patient mononuclear leukocyte trafficking at
the blood-nerve barrier in vitro. A video of merged digital
photomicrographs in real time acquired between 10 and 15 min
following infusion of an untreated GBS (AIDP variant) leukocytes
across a cytokine stimulated monolayer of human primary
endoneurial endothelial cells demonstrates leukocyte rolling, firm
adhesion (phase bright), and some transmigration (phase dark)
(Video 1). Following incubation of the same patient’s leukocytes
with 500
ng/mL function neutralizing mouse anti-human αM integrin antibody
demonstrates significant reduction in adhesion and transmigration in this
model system (Video 2), providing evidence for the role of αM integrin
signaling in pathogenic mononuclear cell trafficking at the blood-nerve
barrier in vitro, with therapeutic implications for GBS.
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